South Australian Health and Medical Research Institute   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Adelaide Australia (2009)

Organization Overview

First Clinical Trial
2013
NCT01863225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

South Australian Health and Medical Research Institute | South Australian Health & Medical Research Institute (SAHMRI) in Adelaide, Australia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 2)

Atherosclerosis (Phase 2)

Coronary Artery Disease (Phase 2)

Disease (Phase 4)

Dyslipidemias (Phase 2)

Fetal Nutrition Disorders (Phase 4)

Infarction (Phase 3)

Lung Diseases (Phase 3)

Mycobacterium Infections (Phase 3)

Myocardial Infarction (Phase 3)

Neurodevelopmental Disorders (Phase 4)

Nutrition Disorders (Phase 4)

ST Elevation Myocardial Infarction (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 29